Tranzyme, Inc. (TZYM) Reports In-Line Q1 Loss of 34c/Share

Tranzyme, Inc. (NASDAQ: TZYM) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $2.61 million versus the consensus estimate of $2.37 million.

For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Endexx Corporation (EDXC) Reports Q1 Loss of $0.01
• United Security Bancshares (UBFO) Reports Q1 EPS of $0.24